Annamaria C.
- Country
- Italy
- Department
- Endocrinology
Research Overview
- J2A-MC-GZGS: A Phase 3, Open-Label Study of Once Daily Orforglipron Compared with Insulin Glargine in Adult Participants with Type 2 Diabetes and Obesity or Overweight at Increased Cardiovascular Risk (ACHIEVE-4)
- Efficacy and Safety Evaluation of Debio 4126, a 12-Week Octreotide Formulation, in Acromegaly Patients Previously Treated with Somatostatin Analogs
- Efficacy and Safety Evaluation of ALXN2420 with Somatostatin Analogs in Adult Acromegaly: A Phase 2 Randomized, Double-Blind, Placebo-Controlled Study
Data & Insights
Has run more than one trial at 19 of 142 partner sites.
Specializations
Metabolic Disorders
The investigator specializes in studying Type 2 Diabetes and its management through innovative therapeutic approaches, with particular attention to patients with concurrent obesity and overweight conditions.
- Diabetes Management
- Weight Management
- Metabolic Control
Their research explores the intersection of metabolic disorders and their impact on patient health outcomes.
Cardiovascular Health
The investigator focuses on understanding and treating cardiovascular diseases in patients with metabolic complications, particularly examining risk factors and therapeutic interventions.
- Cardiovascular Risk Assessment
- Preventive Cardiology
- Cardiometabolic Health
Their work emphasizes the importance of cardiovascular risk management in metabolically compromised patients.
Renal Medicine
The investigator examines chronic kidney disease and its relationship with metabolic disorders, focusing on comprehensive treatment approaches for patients with multiple comorbidities.
- Kidney Disease Management
- Renal Complications
- Metabolic-Renal Interface
Their research addresses the complex interactions between renal function and metabolic health.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.